FDA approves first-ever eye drop that corrects age-related vision loss
By
Alicia Lasek
Nov 02, 2021
The new drug, Vuity, adjusts pupil size and corrects near vision without affecting distance vision, drugmaker Allergan says.
New program will test clinician awareness of drugs known to increase falls in dementia
Aug 23, 2022
The Stop-Falls-D program uses prompts to help reduce the use of drugs that affect the central nervous system, such as sleeping pills, anti-anxiety medications and pain relievers, in patients with dementia.
Kidney injury risk soars with ‘triple whammy’ drug combo
By
Alicia Lasek (f3)
May 12, 2022
When taken together, commonly indicated drugs may lead to acute kidney injury in susceptible patients with high blood pressure, a new study finds.
Diabetes deaths reach 100,000 second year in a row, sparking calls for federal action
By
Alicia Lasek
Feb 01, 2022
The news is cause for alarm, experts say. A congressional commission is calling for broad federal policy changes to tackle the swiftly growing problem.
Retail giants wrap up vaccine clinics, launch new LTC services for ongoing care
By
Alicia Lasek
Apr 23, 2021
CVS Health and Walgreens have completed their final LTC clinics, and are handing the reins to Omnicare and PharMerica to provide ongoing COVID-19 vaccination services in skilled nursing facilities and...
10-year outcomes have improved for older heart attack patients
By
Alicia Lasek (f3)
May 05, 2022
Over a 25-year period, mortality and repeat hospitalization have improved for Medicare beneficiaries who survived a heart attack, a new study finds.
Hypertension, arterial stiffness linked to risk for diabetes
May 16, 2022
The highest risk for diabetes is seen for those with hypertension and arterial stiffness, a new study has found.
VA will not add Alzheimer’s drug Aduhelm to its formulary
By
Alicia Lasek
Aug 12, 2021
The Department of Veterans Affairs has chosen not to include aducanumab (Aduhelm) in its national list of covered drugs, citing risk of adverse events and lack of evidence of positive impact on cognition,...
COVID-19 antiviral drug trials expected to wrap up within months: report
By
Alicia Lasek
Sep 27, 2021
Clinical trials for new COVID-19 antiviral drugs are expected to wrap up by winter, sparking hopes that a daily pill to treat COVID-19 infection is closer to fruition, according to a new report.
Remdesivir cuts risk of severe COVID-19 by 87 percent in non-hospitalized patients
By
Alicia Lasek
Jan 21, 2022
The results suggest that remdesivir (brand name Veklury) could be used to treat outpatients early in the disease course, researchers say. The drug currently is authorized for use only in hospitalized COVID-19...